New England Capital Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$249K Sell
4,319
-2,075
-32% -$119K 0.06% 58
2026
Q1
$388K Buy
6,394
+15
+0.2% +$874 0.11% 42
2025
Q4
$344K Buy
6,379
+164
+3% +$7.89K 0.13% 45
2025
Q3
$280K Buy
6,215
+15
+0.2% +$701 0.12% 50
2025
Q2
$287K Buy
6,200
+13
+0.2% +$638 0.13% 47
2025
Q1
$377K Sell
6,187
-189
-3% -$11K 0.19% 39
2024
Q4
$361K Buy
6,376
+11
+0.2% +$615 0.18% 39
2024
Q3
$329K Buy
6,365
+13
+0.2% +$610 0.17% 40
2024
Q2
$264K Buy
6,352
+14
+0.2% +$626 0.15% 45
2024
Q1
$344K Buy
6,338
+12
+0.2% +$611 0.19% 36
2023
Q4
$325K Buy
6,326
+11
+0.2% +$577 0.2% 37
2023
Q3
$367K Buy
6,315
+9
+0.1% +$551 0.25% 32
2023
Q2
$403K Buy
6,306
+8
+0.1% +$536 0.27% 31
2023
Q1
$437K Buy
6,298
+7
+0.1% +$494 0.31% 28
2022
Q4
$466K Buy
+6,291
New +$474K 0.33% 26

Other funds holding BMY

New England Capital Financial Advisors's BMY Position: Q2 2026 in Review

New England Capital Financial Advisors reduced its Bristol-Myers Squibb (BMY) stake by 32% in Q2 2026, selling an estimated $119K and leaving 4,319 shares worth $249K. The position accounts for 0.06% of the portfolio, ranked #58.

New England Capital Financial Advisors first reported a position in BMY in Q4 2022 and has held it in 15 quarters since. The position peaked at $466K in Q4 2022. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • New England Capital Financial Advisors held 4,319 shares of Bristol-Myers Squibb worth $249K as of Q2 2026.
  • New England Capital Financial Advisors sold 2,075 Bristol-Myers Squibb shares in Q2 2026, an estimated $119K.
  • Bristol-Myers Squibb made up 0.06% of New England Capital Financial Advisors's portfolio in Q2 2026, its #58 holding.
  • New England Capital Financial Advisors first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 15 quarters since.
  • New England Capital Financial Advisors's Bristol-Myers Squibb position peaked at $466K in Q4 2022.
  • 1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on New England Capital Financial Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.